APA (7th ed.) Citation

BG, Z., MW, G., LJ, Z., ZD, L., CH, L., XF, L., . . . YB, D. (2024). Ten-day vonoprazan-amoxicillin dual therapy versus 14-day esomeprazole-amoxicillin dual therapy for first-line Helicobacter pylori eradication: A prospective multicenter randomized controlled trial. Therapeutic advances in gastroenterology, 17, 17562848241309870. https://doi.org/10.1177/17562848241309870

Chicago Style (17th ed.) Citation

BG, Zhou, et al. "Ten-day Vonoprazan-amoxicillin Dual Therapy Versus 14-day Esomeprazole-amoxicillin Dual Therapy for First-line Helicobacter Pylori Eradication: A Prospective Multicenter Randomized Controlled Trial." Therapeutic Advances in Gastroenterology 17 (2024): 17562848241309870. https://doi.org/10.1177/17562848241309870.

MLA (9th ed.) Citation

BG, Zhou, et al. "Ten-day Vonoprazan-amoxicillin Dual Therapy Versus 14-day Esomeprazole-amoxicillin Dual Therapy for First-line Helicobacter Pylori Eradication: A Prospective Multicenter Randomized Controlled Trial." Therapeutic Advances in Gastroenterology, vol. 17, 2024, p. 17562848241309870, https://doi.org/10.1177/17562848241309870.